TKO Group Director Invests Nearly 1 Million in Shares Highlighting Insider Confidence TikTok and YouTube Face Regulatory Scrutiny Over Child Safety Standards from UK Watchdog Microsofts GitHub was positioned to win the AI coding race Outages got in the way Nvidias Blockbuster Quarter China Concession and the 200 Billion Edge Computing Opportunity Obsession and The Mandalorian Grogu Deliver Blockbuster Box Office Results HC Wainwright Lifts Eton Pharmaceuticals Price Target Reaffirms Positive Outlook on Growth Strategy EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains NACCO Industries NC Q1 2026 Earnings EPS of 117 Reported Amid Limited Disclosure BWLP Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Conditions KG Q3 2024 Earnings A Loss of 016 per Share as Stock Declines Health In Tech Inc HIT Q1 2026 Earnings EPS Meets Estimates Stock Slips 26 Labcorp Holdings Inc LH Q1 2026 Earnings EPS Tops Estimates Amid Strong Operational Execution Main Street Capital MAIN Faces Selling Pressure Key Levels to Watch After 272 Decline Lithium Americas LAC Slips 17 Hovers Near Key Support as Lithium Headwinds Persist CareCloud Preferred Stock CCLDO Holds Steady Near Key Support as Traders Assess Yield Appeal Columbus Circle Capital Corp II Warrants CMIIW Remain Flat at 034 as Investors Await Catalyst Covista Inc CVSA Slides Marginally Holding Above Key Support RubioModi Meeting Signals USIndia Energy Cooperation Amid Iran Conflict NOG Q1 2026 Earnings EPS Beats Estimates by 789 Stock Declines OSI Systems OSIS Holds Steady Near 220 Amid Modest Pullback Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress MIND Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain CLLS Q1 2026 Earnings Narrowed Loss Surprises Amid Clinical Focus CISS Q3 2025 Earnings Loss per Share of 058 Shares Decline 55 GPCR Q1 2026 Earnings Narrower Loss Highlights ClinicalStage Progress